awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33421669-39EBB29A-9FD4-4A3F-91A3-DD6A4676EBFB
Q33421669-39EBB29A-9FD4-4A3F-91A3-DD6A4676EBFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421669-39EBB29A-9FD4-4A3F-91A3-DD6A4676EBFB
Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.
P2860
Q33421669-39EBB29A-9FD4-4A3F-91A3-DD6A4676EBFB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421669-39EBB29A-9FD4-4A3F-91A3-DD6A4676EBFB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c41012636e0791c2dbc5424a1d5bc671999996de
P2860
Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.